Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

31P MRS Ischaemic Exercise Optimisation and COPD Myopathy Study

NCT01476072 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01476072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01476072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
31P MRS Ischaemic Exercise Optimisation and COPD Myopathy Study
Lead sponsor
GlaxoSmithKline
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2010
Completion date
August 31, 2011
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrophy, muscular